COMMUNIQUÉS West-GlobeNewswire

FDA Issues Guidance to Improve Collection of Pregnancy Safety Data for Drugs and Biologics
08/05/2026
Recommendations aim to help provide clearer safety information for use during pregnancy White Oak, Md., May 08, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today issued a final guidance for industry, [...]
TOMI Environmental Solutions, Inc. Reports First Quarter 2026 Financial Results and Announces Transformative Letter of Intent to Merge with Carbonium Core, Inc.
08/05/2026
FREDERICK, Md., May 08, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ), a global provider of disinfection and decontamination essentials through its premier Binary Ionization Technology® (BIT [...]
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
08/05/2026
PALO ALTO, Calif., May 08, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a biopharmaceutical company focused on developing medicines for genetic conditions, today [...]
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08/05/2026
BEDFORD, Mass., May 08, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular” or the “Company”), an integrated biopharmaceutical company committed to redefining the retina experience, today announced [...]
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08/05/2026
WESTLAKE VILLAGE, Calif., May 08, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, [...]
Shiny Smile Veneers Under Investigation: Evaluating the Dentist-Designed Custom Fit Snap-On Top & Bottom Veneer Claims
08/05/2026
How Shiny Smile Veneers' At-Home Snap-On Custom Fit System, Dr. Dean's Dentist-Designed Process, FDA-Approved Material Claims, 60-Day Guarantee Terms, and Consumer Complaints and Reviews Stack Up in 2026 Richardson, TX [...]
More Life Summit 2026 Brings the World's Leading Voices in Longevity, Performance, Faith & Purpose to Miami this October
08/05/2026
Two-Day Premium Experience at the James L. Knight Center Headlined by Human Biologist Gary Brecka and 2x Mr. Olympia Derek Lunsford, with Title Sponsor AllCore360° MIAMI, Fl., May 08, 2026 (GLOBE NEWSWIRE) -- [...]
Her Bodhi Claims Evaluated: Meno & Hormonal Support for Women by HerBodhi Under Investigation
08/05/2026
Her Bodhi Meno Ingredient Research: KSM-66 Ashwagandha, Black Cohosh, and Red Clover Ingredients, Side Effects, Pricing, and Refund Policy for Menopause Support in 2026 Los Angeles, CA, May 08, 2026 (GLOBE NEWSWIRE) -- [...]
Fitness Online Named “Best Fitness Mobile App” in 10th Annual MedTech Breakthrough Awards Program
08/05/2026
Landmark 10th Annual Awards Program Recognizes the Most Innovative Digital Health and Medical Technology Solutions Worldwide LOS ANGELES, May 08, 2026 (GLOBE NEWSWIRE) -- MedTech Breakthrough , an independent market [...]
Major Shareholder Announcement
08/05/2026
Company Announcement Major shareholder announcement for Genmab A/S COPENHAGEN, Denmark; May 8, 2026 – Genmab A/S (Nasdaq: GMAB) announces under reference to Section 30 of the Danish Capital Markets Act that Orbis [...]
Erdem Health Group Enters Türkiye’s TURQUALITY Program
08/05/2026
The recognition supports Istanbul-based healthcare group’s international brand strategy and reinforces its quality-focused growth in health tourism Erdem Health Group has been accepted into TURQUALITY®, Türkiye’s state- [...]
Cytokinetics Announces Closing of Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $805 Million
08/05/2026
SOUTH SAN FRANCISCO, Calif., May 08, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the closing of an underwritten public offering of 11,338,028 shares of its common stock, including [...]
Le Consortium international de recherche sur le cancer de l’ovaire annonce une nouvelle bourse pour des recherches propulsées par l’IA, visant à faire progresser les découvertes fondées sur les données
08/05/2026
Le 8 mai, à l’occasion de la Journée mondiale du cancer de l’ovaire, le Consortium international de recherche sur le cancer de l’ovaire annonce une deuxième bourse d’une valeur de 1 M$ US assortie d’un soutien [...]
Allarity Therapeutics CEO to Present at Precision Medicine Forum Europe 2026 in Stockholm
08/05/2026
TARPON SPRINGS, Fla., May 8, 2026 – Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib (2X-121)—a differentiated [...]
Hyperion DeFi Announces Closing of Public Offering of Common Stock
08/05/2026
DALLAS, May 08, 2026 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”), the first U.S. publicly listed DeFi company building on Hyperliquid, today announced that it has closed its [...]
Moleculin Biotech Secures Strategic Additional Patent, Strengthening Global Positioning of Annamycin
08/05/2026
Solid Intellectual Property Protection Across Four Continents Ahead of Pending Phase 3 Data Release HOUSTON, May 08, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) (“Moleculin” or the “Company”), [...]
Global Ovarian Cancer Research Consortium Announces Next AI Accelerator Grant to Advance Data-Driven Discovery
08/05/2026
On World Ovarian Cancer Day, May 8, the Global Ovarian Cancer Research Consortium announces a second $1 million USD grant along with AWS compute support to power research to improve ovarian cancer survival rates TORONTO [...]
Tvardi Therapeutics Announces First Quarter 2026 Results and Provides Business Update
08/05/2026
Topline results from healthy volunteer study and clinical development strategy for next-generation STAT3 inhibitor, TTI-109, anticipated in June Topline data from Phase 2 trial of TTI-101 in hepatocellular carcinoma ( [...]
Boundless Bio Reports First Quarter 2026 Financial Results and Business Highlights
08/05/2026
Enrollment proceeding in KOMODO-1 first-in-human clinical trial of BBI-940 $93 million in cash provides runway through expected clinical proof-of-concept readout for KOMODO-1 SAN DIEGO, May 08, 2026 (GLOBE NEWSWIRE) -- [...]

Pages